Yanda International Hospital
| China | Turkey | Austria | |
| Plasmapheresis | from $2,200 | from $1,200 | from $2,000 |
| Selective Apheresis | from $3,500 | from $1,550 | - |
| Plasma Exchange | from $2,400 | from $3,900 | - |
| DFPP Plasmapheresis | from $2,800 | from $1,850 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Lupus erythematosus treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lupus erythematosus treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lupus erythematosus treatment journey.
Lupus treatment in China utilizes a combination of glucocorticoids, antimalarials, and immunosuppressants. Approximately 73% of patients receive hydroxychloroquine as background therapy. Standard protocols include mycophenolate mofetil and cyclophosphamide for severe cases. Advanced biotherapies like belimumab and the domestically developed telitacicept are also approved for systemic lupus erythematosus.
Bookimed Expert Insight: Patients at JCI-accredited facilities such as Yanda International Hospital benefit from a dual-track approach. High-volume Class A Level III clinics often combine advanced selective apheresis with standard pharmaceutical protocols. This integration aims to rapidly clear autoantibodies in refractory cases while maintaining long-term drug stability. This strategy is particularly common in Beijing for complex systemic presentations.
Patient Consensus: Patients note that high-dose steroids often cause rapid weight gain early in treatment. They emphasize the importance of getting baseline eye exams before starting long-term hydroxychloroquine therapy.
Integrated lupus therapy in China combines Western immunosuppression with Traditional Chinese Medicine (TCM) to improve outcomes. This dual approach achieves an 86% efficacy rate by balancing internal systems. Hospitals use TCM to lower steroid dosages. It also helps manage inflammation safely.
Bookimed Expert Insight: While many seek TCM for its natural reputation, China's highest-tier hospitals like Yanda International Hospital actually lead the integration. These JCI-accredited institutions serve 2,500,000 patients annually and use 28,500 modern technologies. The secret is that they do not replace Western protocols. Instead, they use TCM in a Class A clinical setting. This ensures that traditional herbs are monitored alongside rigorous Western blood diagnostics. This high-volume environment allows doctors to refine exactly which herbal formulas safely complement modern biologics.
Patient Consensus: Patients note that TCM is most effective for managing fatigue and joint pain rather than curing the disease. They emphasize that you must always tell your rheumatologist about herbal supplements to avoid dangerous drug interactions.
China offers advanced therapies for refractory lupus, including the home-grown biologic telitacicept and cutting-edge CAR T-cell therapy. Telitacicept is a dual-target fusion protein. It inhibits both BLyS and APRIL. Specialized centers also provide advanced filtration techniques like Double Filtration Plasmapheresis to remove harmful antibodies.
Bookimed Expert Insight: Yanda International Hospital in Beijing holds Class A Level III status, the highest in China. This accreditation is rare for hospitals focusing on multiple international service languages. With a capacity of 3,000 beds, such centers manage massive patient volumes exceeding 2,500,000 annually. This high concentration of clinical data often leads to faster access to experimental protocols compared to smaller regional clinics.
Patient Consensus: Patients note that accessing the newest CAR-T trials often requires significant self-funding. Many emphasize the importance of monitoring for infections and flares immediately after these intensive treatments.
Peking Union Medical College Hospital and Renji Hospital are top institutions for lupus care in China. These centers specialize in systemic lupus erythematosus (SLE) through advanced rheumatology departments. Renji Hospital is a leader in clinical trials and cell therapy research for autoimmune conditions.
Bookimed Expert Insight: While academic centers like Peking Union handle the highest patient volumes, Yanda International Hospital offers a distinct advantage for international travelers. This JCI-accredited facility is one of only a few Class A Level III clinics in China that actively caters to foreign patients. It provides specialized 21-day inpatient programs. This structured timeline is often more manageable for international logistics than the open-ended wait times at general public hospitals.
Patient Consensus: Patients note that top Beijing hospitals are excellent for managing flares. However, travelers should prepare for long wait times and bring their own medication supplies to avoid local shortages.
Chinese medical protocols fully accept international patients for systemic lupus erythematosus (SLE) care. Specialized centers in Beijing and Shanghai provide dedicated international departments with English-speaking staff. Patients access advanced therapies like DFPP plasmapheresis or stem cell protocols using medical invitation letters for visa processing.
Bookimed Expert Insight: Yanda International Hospital serves over 2,500,000 patients annually and belongs to the highest level of Chinese hospital ranking. While public hospitals serve massive volumes, their JCI-accredited international units focus specifically on non-residents. This infrastructure ensures same-day specialist registration which is much faster than Western waiting lists.
Patient Consensus: Patients note it is essential to target Tier 1 hospitals with international desks for better coordination. Translating all medical records into Mandarin beforehand helps doctors confirm protocol eligibility during the initial visit.
Chinese guidelines prioritize rigorous sun protection and specific chemical avoidance to prevent lupus flares. Patients must use high-SPF sunscreen and wear protective clothing to block ultraviolet radiation. Avoiding hair dyes and eyebrow tattoos is also critical for reducing systemic disease recurrence.
Bookimed Expert Insight: JCI-accredited centers like Yanda International Hospital treat over 2,000,000 patients yearly using integrated protocols. These facilities combine international medical standards with traditional Chinese approaches to maximize recovery. This high-volume expertise allows doctors to personalize recovery plans using both modern labs and traditional insights.
Patient Consensus: Patients note that rheumatologists emphasize zero sun exposure and the use of SPF 100+ daily. Many recommend checking all traditional herbs with a specialist to ensure they do not trigger flares.
Stem cell therapy is a legitimate, government-approved treatment for systemic lupus erythematosus in China as of early 2026. Authorised facilities provide mesenchymal stem cells to regulate immune responses in severe, refractory cases. This therapy is restricted to top-tier Class 3A public research hospitals and specific medical zones.
Bookimed Expert Insight: While small clinics may market stem cell services, true legitimacy rests with Class 3A hospitals. Yanda International Hospital holds JCI accreditation and Class A level III status. These credentials are the highest in China. Australian patients should prioritise hospitals with these rankings to follow international safety protocols.
Patient Consensus: Patients suggest treating stem cell therapy as an intensive option for the most severe cases. They recommend keeping a home GP involved. They also suggest verifying formal clinical trial data before starting treatment in China.
Chinese hospitals treat Lupus erythematosus using a dual-track method. This approach pairs Western pharmaceuticals with Traditional Chinese Medicine (TCM). JCI-accredited facilities like Yanda International Hospital follow these protocols for rapid remission. Treatment often features domestic biologics like Telitacicept to reduce immune activity.
Bookimed Expert Insight: Yanda International Hospital serves over 2,500,000 patients annually despite focusing only on adults. This volume allows their rheumatology departments to manage rare lupus presentations. Beijing-based specialists often combine these Western protocols with TCM in one multidisciplinary plan. This helps in complex cases requiring long-term immune regulation.
Patient Consensus: Patients note care is typically rheumatology-led. They often compare these medication regimens and multidisciplinary hospitalisation experiences to standard care in Australia when evaluating results.
Modern biologic therapies for Lupus erythematosus are widely available in China. Chinese specialists use treatments like Telitacicept (RC18) and Belimumab to treat active systemic cases. These therapies help control immune responses. They are accessible at JCI-accredited facilities in major cities like Beijing.
Bookimed Expert Insight: China has become a hub for lupus biologics by developing unique home-grown treatments. While most countries only offer Belimumab, Chinese clinics provide dual-target therapies. These may show better results for kidney-related lupus complications. Local manufacturing often provides a more stable supply compared to imported drugs.
Patient Consensus: Patients find that availability depends heavily on the hospital tier and city. Many suggest seeing a specialist rheumatologist at a top-tier hospital. This helps to confirm the specific biologic is currently in stock.
Specialists in China treat lupus nephritis by combining international protocols with traditional approaches. They use intensive drug regimens and blood purification techniques like plasmapheresis. JCI-accredited facilities in Beijing provide integrated therapy. This includes tailored immunosuppression and biologics to control severe kidney inflammation.
Bookimed Expert Insight: Many countries separate traditional and modern medicine, but China's top hospitals integrate them. Yanda International Hospital serves 2,500,000 patients annually using this dual-track system. This high volume allows specialists to manage complex Class III and IV cases frequently. Patients gain access to both standard immunosuppressants and unique domestic biologics like Telitacicept.
Patient Consensus: Patients note the importance of regular renal biopsies and frequent protein checks in China. They highlight that clear communication about steroid regimens and hospitalisation protocols helps manage expectations.
Traditional Chinese Medicine (TCM) is a standard integrative therapy for lupus in China. Specialists use it alongside Western medical treatments. This combined approach often includes Chinese herbal compounds and immunosuppressive drugs. It helps manage symptoms and aims to reduce steroid dosages while preventing relapses.
Bookimed Expert Insight: Yanda International Hospital in Beijing serves 2,500,000 patients annually and holds JCI accreditation. This high volume allows doctors to gain massive experience in complex rheumatology cases. Patients benefit because these Class A level III hospitals provide the highest tier of medical care available in China.
Patient Consensus: Patients in China view TCM as a supportive tool rather than a replacement for hospital-led rheumatology care. They often highlight the importance of balancing herbal treatments with prescribed immunosuppressants to prevent flares.